Dechert LLP

Dechert LLP has secured favorable outcomes for pharma and medical device clients in appellate, federal, and state courts, handling complex multi-district and state-court product liability litigations. Notably, the firm has achieved significant victories through persuasive dispositive motions, often reducing or eliminating plaintiff pools. The product liability and mass torts practice is co-chaired by Los Angeles’ Jay Bhimani, an experienced trial lawyer, including in high-stakes bellwether cases. New York-based co-chair Douglas E. Fleming III’s extensive litigation experience includes examining and preparing witnesses for deposition, Daubert hearings, and trial and legislative testimony. New York-based Mark Cheffo, who co-chairs the global litigation practice, leads complex, high-profile pharma litigations, managing all stages from negotiation, through pre-trial proceedings to trial. Cheffo has been a key figure in the firm’s representation of GlaxoSmithKline as lead national counsel in the Zantac mass tort litigation. Also in New York, special counsel Sheila L. Birnbaum has vast experience representing leading pharma companies in complex product liability and mass torts litigation.